Gene Therapy For Rare Forms Of Blindness Will Cost Nearly Half A Million Per Eye – IFLScience
IFLScience |
Gene Therapy For Rare Forms Of Blindness Will Cost Nearly Half A Million Per Eye
IFLScience The pharmaceutical company behind a gene therapy for inherited blindness has announced the product’s price, and sticker shock has sent news outlets worldwide into a collective tizzy. Spark Therapeutics plans to charge $425,000 per eye for the therapy … Price tag on gene therapy for rare form of blindness: $850KConcord Monitor |
|
FDA Warns Stem Cell Supplier Over Unapproved Treatment
Regulatory Focus The US Food and Drug Administration (FDA) on Wednesday warned stem cell product supplier American CryoStem Corporation for marketing an unapproved product after the agency inspected the company’s Eatontown, New Jersey site in July. The warning letter … |
Investor’s Business Daily |
Audentes Therapeutics Stock Rocketed On Gene Therapy Trial In …
Investor’s Business Daily Audentes rocketed to an all-time high as its gene therapy showed promising results in treating a muscular disorder. Audentes’ gene therapy AT132 shows positive effect in XLMTM study; shares ahead 13% premarketSeeking Alpha BOLD | Stocks Latest Headlines for Audentes Therapeutics Inc – Barchart.comBarchart.com |